Background. No marker reflecting the patho-biology of meniscal degeneration (MD) is established so far. NITEGE is a hexapeptide fragments produced when aggrecan is cleaved. Methods. In vitro IL-1 exposition of bovine menisci (n = 4) caused extracellular NITEGE deposits detected by immunofluorescence. A retrospective immunohistochemical analysis of (n = 60) patients after meniscectomy for NITEGE deposits was performed. MD was graded as follows: no/little (grade 0/1), medium (grade 2) or severe (grade 3). Results. NITEGE deposits in areas of degeneration were demonstrated in 55% of the patients with grade 2 or 3 MD (PPV & specificity 100%), while no extracellular NITEGE deposits in the menisci with grade 0 or 1 MD could be detected. Age correlated with NITEGE deposits (r = 0.46) and grade of MD (r = 0.48). NITEGE-positive cell density and size were significantly higher close to a tear (p < 0, 001). Interpretation. Extracellular NITEGE deposits may be regarded as markers of medium and severe MD and might be used in diagnostic histopathology.
CITATION STYLE
Knoess, P., Jakobs, M., Otto, M., Mollenhoff, G., Krukemeyer, M. G., & Krenn, V. (2011). NITEGE-Expression in Meniscal Matrix. A New, Immunohistochemical Marker of Meniscal-Tissue Degeneration. Journal of Orthopaedics and Trauma, 1. https://doi.org/10.4303/jot/235377
Mendeley helps you to discover research relevant for your work.